Mastek (MASTEK) Q2 24/25 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 24/25 earnings summary
19 Jan, 2026Executive summary
Achieved 6.7% quarter-on-quarter and 13.3% year-on-year revenue growth, surpassing $100mn in quarterly revenue, with strong profitability and robust performance in North America and the U.K.
North America posted 18% sequential growth, driven by new client wins and expansion in healthcare and commercial verticals.
Recognized with multiple industry awards and featured in analyst reports for digital transformation and AI services.
Secured significant new deals across government, healthcare, financial services, and retail sectors globally.
Consolidated unaudited financial results for the quarter and six months ended September 30, 2024, were reviewed and approved by the Board and auditors, with no material misstatements identified.
Financial highlights
Q2FY25 revenue was ₹867.4 crore (₹86,739 lakhs), up 6.7% QoQ and 13.3% YoY; operating EBITDA at ₹143.1 crore, up 15.5% QoQ and 16.3% YoY.
PAT for Q2FY25 at ₹128.7 crore (₹12,865 lakhs), up 79.9% QoQ and 97.1% YoY; PAT margin improved to 14.7%.
12-month order backlog at ₹2,194.7 crore, up 1.2% QoQ and 17.9% YoY.
H1FY25 revenue at ₹1,680.3 crore (₹1,68,028 lakhs), up 12.7% YoY; PAT at ₹200.1 crore (₹20,015 lakhs), up 44.2% YoY.
Basic EPS for Q2FY25 was ₹41.69, compared to ₹20.52 in Q2 FY24; six-month basic EPS was ₹64.87, up from ₹43.47 year-over-year.
Outlook and guidance
Management remains cautiously optimistic, monitoring macro factors like elections and government policy changes in key markets.
Strategic focus on healthcare, public sector, Oracle & Salesforce, and AI-driven innovation, with emphasis on account mining and expanding GenAI solutions.
No formal revenue growth guidance provided; focus remains on consistent growth amid macro uncertainties and seasonal furloughs.
The group expects synergies and future taxable profits from recent acquisitions, particularly in the US, to support continued growth.
Margin profile expected to be maintained or improved, with operating levers to offset wage hike impacts.
Latest events from Mastek
- Q1 revenue up 12.1% YoY, order backlog up 23%, margin dips, but H2 outlook strong.MASTEK
Q1 24/253 Feb 2026 - EBITDA margin reached 16.1% with 4.2% YoY revenue growth and strong order backlog.MASTEK
Q3 25/2621 Jan 2026 - Q3 revenue grew 10.9% YoY to ₹869.5 crore ($103M), with robust order wins and AI-driven growth outlook.MASTEK
Q3 24/2510 Jan 2026 - Double-digit revenue and profit growth, strong UK & Europe, AI focus, and ₹16/share dividend.MASTEK
Q4 24/252 Dec 2025 - Q2FY26 saw strong revenue growth, margin gains, and major AI-led wins, led by UK & Europe.MASTEK
Q2 25/2624 Nov 2025 - Q1FY26 delivered strong growth, margin gains, and strategic wins, led by UK and Europe.MASTEK
Q1 25/2624 Nov 2025